Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 3 studies | 45% ± 17% |
Insufficient scRNA-seq data for expression of MELK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 95% | 927.75 | 1720 / 1809 | 90% | 20.68 | 425 / 472 |
intestine | 55% | 207.72 | 532 / 966 | 97% | 33.91 | 509 / 527 |
lung | 64% | 116.75 | 372 / 578 | 86% | 27.10 | 994 / 1155 |
stomach | 48% | 156.31 | 174 / 359 | 97% | 31.96 | 276 / 286 |
esophagus | 42% | 313.55 | 614 / 1445 | 99% | 38.43 | 182 / 183 |
bladder | 29% | 25.62 | 6 / 21 | 91% | 33.79 | 460 / 504 |
breast | 24% | 29.96 | 109 / 459 | 87% | 25.36 | 971 / 1118 |
uterus | 9% | 14.35 | 15 / 170 | 98% | 47.01 | 450 / 459 |
ovary | 11% | 19.27 | 19 / 180 | 94% | 24.87 | 404 / 430 |
tonsil | 0% | 0 | 0 / 0 | 100% | 48.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.41 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 97% | 31.51 | 28 / 29 |
spleen | 91% | 229.95 | 220 / 241 | 0% | 0 | 0 / 0 |
pancreas | 10% | 9.73 | 32 / 328 | 69% | 11.16 | 122 / 178 |
liver | 17% | 43.12 | 38 / 226 | 46% | 6.65 | 188 / 406 |
adrenal gland | 40% | 44.91 | 104 / 258 | 14% | 2.86 | 32 / 230 |
peripheral blood | 48% | 760.36 | 450 / 929 | 0% | 0 | 0 / 0 |
brain | 1% | 1.50 | 31 / 2642 | 39% | 8.66 | 274 / 705 |
adipose | 37% | 44.17 | 441 / 1204 | 0% | 0 | 0 / 0 |
kidney | 21% | 43.60 | 19 / 89 | 13% | 1.81 | 118 / 901 |
prostate | 16% | 18.67 | 40 / 245 | 15% | 1.76 | 74 / 502 |
thymus | 11% | 12.42 | 73 / 653 | 14% | 3.80 | 85 / 605 |
blood vessel | 14% | 14.09 | 187 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.54 | 6 / 80 |
heart | 7% | 7.89 | 58 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.23 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008283 | Biological process | cell population proliferation |
GO_0030097 | Biological process | hemopoiesis |
GO_0061351 | Biological process | neural precursor cell proliferation |
GO_0006915 | Biological process | apoptotic process |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0006468 | Biological process | protein phosphorylation |
GO_0008631 | Biological process | intrinsic apoptotic signaling pathway in response to oxidative stress |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005938 | Cellular component | cell cortex |
GO_0005737 | Cellular component | cytoplasm |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0008289 | Molecular function | lipid binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MELK |
Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) |
Synonyms | KIAA0175 |
Description | FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis. Plays a key role in cell proliferation and carcinogenesis. Required for proliferation of embryonic and postnatal multipotent neural progenitors. Phosphorylates and inhibits BCL2L14, possibly leading to affect mammary carcinogenesis by mediating inhibition of the pro-apoptotic function of BCL2L14. Also involved in the inhibition of spliceosome assembly during mitosis by phosphorylating ZNF622, thereby contributing to its redirection to the nucleus. May also play a role in primitive hematopoiesis. . |
Accessions | ENST00000543751.5 [Q14680-6] ENST00000536329.5 [Q14680-5] A0A0D9SFL8 ENST00000495529.5 ENST00000298048.7 [Q14680-1] A0A0D9SGI4 Q14680 ENST00000626154.2 ENST00000536987.5 [Q14680-4] A0A0D9SFF9 ENST00000541717.4 [Q14680-7] A0A0D9SFB9 ENST00000627766.2 ENST00000536860.5 [Q14680-8] ENST00000625974.2 ENST00000545008.5 [Q14680-2] |